Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
Clinical trial NCT07107750 · RECRUITING
Trial details
- NCT number
- NCT07107750
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-27
- Primary completion
- 2030-06-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.